IL327411A - תכשירים רוקחיים הכוללים מרליקסיבט ושימושים שלהם - Google Patents

תכשירים רוקחיים הכוללים מרליקסיבט ושימושים שלהם

Info

Publication number
IL327411A
IL327411A IL327411A IL32741126A IL327411A IL 327411 A IL327411 A IL 327411A IL 327411 A IL327411 A IL 327411A IL 32741126 A IL32741126 A IL 32741126A IL 327411 A IL327411 A IL 327411A
Authority
IL
Israel
Prior art keywords
maralixibat
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL327411A
Other languages
English (en)
Inventor
Parag Ved
Original Assignee
Mirum Pharmaceuticals Inc
Parag Ved
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mirum Pharmaceuticals Inc, Parag Ved filed Critical Mirum Pharmaceuticals Inc
Publication of IL327411A publication Critical patent/IL327411A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
IL327411A 2023-10-05 2023-10-05 תכשירים רוקחיים הכוללים מרליקסיבט ושימושים שלהם IL327411A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2023/034580 WO2025075624A1 (en) 2023-10-05 2023-10-05 Pharmaceutical compositions comprising maralixibat and uses thereof

Publications (1)

Publication Number Publication Date
IL327411A true IL327411A (he) 2026-05-01

Family

ID=95283600

Family Applications (1)

Application Number Title Priority Date Filing Date
IL327411A IL327411A (he) 2023-10-05 2023-10-05 תכשירים רוקחיים הכוללים מרליקסיבט ושימושים שלהם

Country Status (3)

Country Link
AU (1) AU2023468766A1 (he)
IL (1) IL327411A (he)
WO (1) WO2025075624A1 (he)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2577852A1 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Pharmaceutical dosage forms comprising a low-solubility drug and a polymer
NZ600123A (en) * 2009-11-30 2015-04-24 Aptalis Pharmatech Inc Compressible-coated pharmaceutical compositions and tablets and methods of manufacture
PL2665471T3 (pl) * 2011-01-19 2018-06-29 Pathologica, Llc. Doustne farmaceutyczne postacie dawkowane o kontrolowanym uwalnianiu zawierające mgbg
EP2968230A2 (en) * 2013-03-15 2016-01-20 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
PT3435996T (pt) * 2016-03-31 2025-05-13 Genfit Elafibranor para utilização no tratamento de colangite biliar primária
TW202333724A (zh) * 2021-11-05 2023-09-01 美商米魯姆製藥公司 以迴腸膽酸轉運蛋白(ibat)抑制劑治療以增加無事件存活期(efs)

Also Published As

Publication number Publication date
AU2023468766A1 (en) 2026-03-26
WO2025075624A1 (en) 2025-04-10

Similar Documents

Publication Publication Date Title
GB2611642B (en) Pharmaceutical and cosmetic compositions comprising secretomes
IL320856A (he) שילובים פרמצבטיים ושימושים בהם
PT4153133T (pt) Composições farmacêuticas injetáveis e utilizações das mesmas
ZA202105586B (en) Pharmaceutical delivery compositions and uses thereof
IL300090A (he) תכשירי רוקחות המכילים venglustat
IL326970A (he) תכשירי רוקחות המכילים ניפוקלימאב
IL319382A (he) תכשיר רוקחות ושימוש בו
GB202215065D0 (en) Compositions and uses thereof
GB202209335D0 (en) Compositions and uses thereof
EP4364735A4 (en) PHARMACEUTICAL COMPOSITION AND USE THEREOF
GB202002926D0 (en) Compositions and uses thereof
CA3304568A1 (en) Pharmaceutical compositions comprising maralixibat and uses thereof
EP4125873A4 (en) PHARMACEUTICAL COMPOSITIONS AND USE THEREOF
CA3307498A1 (en) Pharmaceutical compositions and uses thereof
HK40076361A (en) Aspacytarabine pharmaceutical compositions and uses thereof
EP4100020A4 (en) PHARMACEUTICAL ASPACYTARABINE COMPOSITIONS AND USES THEREOF
HK40077387A (en) Pharmaceutical compositions and their uses
GB202507879D0 (en) Pharmaceutical composition and uses
NL2027551A (en) 1immunogenic polypeptides and pharmaceutical compositions
GB202215064D0 (en) Compositions and uses thereof
GB202213726D0 (en) Compositions and uses thereof
GB202003316D0 (en) Pharmaceutical compositions comprising dasatinib anhydrous and uses thereof
GB202210105D0 (en) Compositions and uses thereof
GB202210107D0 (en) Compositions and uses thereof
GB202210106D0 (en) Compositions and uses thereof